Patents by Inventor Mu-Lan Lee

Mu-Lan Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20230241030
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: April 5, 2023
    Publication date: August 3, 2023
    Inventors: Anuradha V. Gore, Kevin S. Warner, Chetan P. Pujara, Richard S. Graham, Ajay P. Parashar, Mu-Lan Lee, Robert S. Jordan, Sukhon Likitlersuang
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20210275497
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: March 16, 2021
    Publication date: September 9, 2021
    Inventors: Anuradha V. Gore, Kevin S. Warner, Chetan P. Pujara, Richard S. Graham, Ajay P. Parashar, Mu-Lan Lee, Robert S. Jordan, Sukhon Likitlersuang
  • Quaternary ammonium alkyl esters as stable prodrugs
    Patent number: 9981938
    Abstract: Disclosed herein are compounds according to Formulas 1-12, compositions comprising these compounds, and methods of lowering intraocular pressure (IOP) or causing hair growth, and methods of using the same.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: May 29, 2018
    Assignee: ALLERGAN, INC.
    Inventors: Robert M. Burk, David W. Old, Wha Bin Im, Richard S. Graham, Mu-Lan Lee
  • QUATERNARY AMMONIUM ALKYL ESTERS AS STABLE PRODRUGS
    Publication number: 20170081304
    Abstract: Disclosed herein are compounds according to Formulas 1-12, compositions comprising these compounds, and methods of lowering intraocular pressure (IOP) or causing hair growth, and methods of using the same.
    Type: Application
    Filed: May 12, 2015
    Publication date: March 23, 2017
    Inventors: Robert M. Burk, David W. Old, Wha Bin Im, Richard S. Graham, Mu-Lan Lee
  • Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
    Patent number: 8952051
    Abstract: The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: February 10, 2015
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Ajay Parashar, Chetan Pujara, Richard Graham, Mu-Lan Lee
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20140287988
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: December 9, 2013
    Publication date: September 25, 2014
    Applicant: ALLERGAN, INC.
    Inventors: ANURADHA V. GORE, KEVIN S. WARNER, CHETAN P. PUJARA, RICHARD S. GRAHAM, AJAY P. PARASHAR, MU-LAN LEE, ROBERT S. JORDAN, SUKHON LIKITLERSUANG
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20130005665
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 3, 2013
    Inventors: Anuradha V. Gore, Kevin S. Warner, Chetan P. Pujara, Richard S. Graham, Ajay Parashar, Mu-Lan Lee, Robert S. Jordan, Sukhon Likitlersuang
  • OPHTHALMIC FORMULATIONS CONTAINING SUBSTITUTED GAMMA LACTAMS AND METHODS FOR USE THEREOF
    Publication number: 20110105581
    Abstract: The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
    Type: Application
    Filed: November 4, 2010
    Publication date: May 5, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Ajay Parashar, Chetan Pujara, Richard Graham, Mu-Lan Lee